Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Watch Anglo American (AAL) by Cliff D'Arcy in The Motley Fool
- Avoid ActiveOps (AOM) by Steve Moore in ShareProphets
- Overweight Relx plc (REL) by JP Morgan
- Avoid SRT Marine Systems (SRT) by Steve Moore in ShareProphets
- Sell WPP (WPP) by UBS
- Buy NextEnergy Solar Fund Limited Red (NESF) by Gaurav Sharma in The Motley Fool
- Buy Octopus Renewables Infrastructure Trust (ORIT) by Gaurav Sharma in The Motley Fool
- Buy The Renewables Infrastructure Group Limited (TRIG) by Gaurav Sharma in The Motley Fool
- Buy Aviva (AV.) by Christopher Ruane in The Motley Fool
- Buy Legal & General Group (LGEN) by Christopher Ruane in The Motley Fool
- Buy Persimmon (PSN) by Paul Summers in The Motley Fool
- Hold Anglo American (AAL) by DZ Bank
- Buy Unilever (ULVR) by Stephen Wright in The Motley Fool
- Neutral Unilever (ULVR) by Goldman Sachs
- Buy British American Tobacco (BATS) by Charlie Keough in The Motley Fool
- Sector Perform Unilever (ULVR) by RBC Capital
- Buy Anglo Asian Mining (AAZ) by Hot Stock Rockets in ShareProphets
- Buy Croda International (CRDA) by UBS
- Avoid Videndum (VID) by Steve Moore in ShareProphets
- Buy Reckitt Benckiser Group (RKT) by DZ Bank
N4 Pharma (N4P) Share Price
Health Care Sector
NOTE: This is based on 2 open tips for N4 Pharma (N4P)
| Latest Bid : 0.80p | Latest Ask : 0.85p |
| High Today : 0.90p | Low Today : 0.80p |
| This Years High : 3.07p | This Years Low : 0.80p |
| Volume : 2,385,001 | MKT Cap : £2.2M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
N4 Pharma (N4P) Overview
We're N4 Pharma, a specialist pharmaceutical company developing a novel silica nanoparticle delivery system for vaccines and therapeutics for licensing to pharmaceutical and biotech partners. This nanoparticle has the potential to help commercialise cancer immunotherapy drugs and improve the effectiveness of viral vaccines.N4 Pharma (N4P) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Risky Buy | Ocean Capital | Premium Only | 2018-01-16 10:00:00 16/01/2018 | -24.23% |
| Risky Buy | Ocean Capital | Premium Only | 2017-08-08 16:20:00 08/08/2017 | 254.19% |
N4 Pharma (N4P) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 0.80p | Latest Ask : 0.85p |
| High Today : 0.90p | Low Today : 0.80p |
| This Years High : 3.07p | This Years Low : 0.80p |
| Volume : 2,385,001 | MKT Cap : £2.2M |
N4 Pharma Overview
We're N4 Pharma, a specialist pharmaceutical company developing a novel silica nanoparticle delivery system for vaccines and therapeutics for licensing to pharmaceutical and biotech partners. This nanoparticle has the potential to help commercialise cancer immunotherapy drugs and improve the effectiveness of viral vaccines.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest N4 Pharma Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Risky Buy | Ocean Capital | Premium Only | 2018-01-16 10:00:00 16/01/2018 | -24.23% |
| Risky Buy | Ocean Capital | Premium Only | 2017-08-08 16:20:00 08/08/2017 | 254.19% |